Turmeric
Last reviewed October 2026 · Based on 25 studies
Bottom line
Several meta-analyses find curcumin eases knee osteoarthritis pain in short trials, though results vary widely. Blood markers of inflammation fall in trials, but these are not disease outcomes. Liver injury is rare and has been reported, mostly with high-dose, high-absorption products.
What it helps with
- Eases knee osteoarthritis pain — Benefit, evidence grade C (Limited). Meta-analyses of mostly short trials; downgraded for inconsistency (I² 86%) and moderate risk of bias.
- Pain relief similar to NSAIDs — Benefit, evidence grade C (Limited). Two meta-analyses found similar pain relief to NSAIDs, based on short, varied trials with moderate risk of bias; downgraded for inconsistency and risk of bias.
- Reduces inflammation — Benefit, evidence grade B (Moderate). Meta-analysis of 66 RCTs; downgraded for surrogate markers rather than disease outcomes.
- Eases rheumatoid arthritis symptoms — Benefit, evidence grade C (Limited). Six trials (539 people); outcomes partly lab markers such as ESR; downgraded for surrogate outcomes and few trials.
- Can cause liver injury — Harm, evidence grade C (Limited). Case reports and case series only; causation supported by positive dechallenge; rate unknown.
What it is
Curcuminoids, mainly curcumin, come from the turmeric rhizome, and the body absorbs them poorly on their own [1]. Supplements come as standard extracts and as enhanced-absorption forms, such as micellar preparations, colloidal suspensions and products combined with piperine [1].
What the research says
Knee osteoarthritis pain has the most evidence. An analysis of 11 earlier meta-analyses found curcumin significantly lowered visual-analogue and WOMAC pain scores [2]. A 2021 meta-analysis of 16 trials (1,810 adults) found turmeric extracts reduced knee pain compared with placebo, with an effect of -0.82 and wide variation between trials [3]. Pain relief looks similar to NSAIDs: a 2021 review found similar effects [3], and a 2022 review found no significant difference from active treatments, including NSAIDs [4]. A 2026 combination trial containing 500 mg of curcumin found no pain difference from placebo over 12 weeks [5].
Across 66 randomised trials, turmeric or curcumin lowered CRP, TNF-α and IL-6, but IL-1β did not change [6]. In rheumatoid arthritis, six trials with 539 people found improved disease activity (DAS28) [7].
Doses used in studies
Arthritis trials used doses from 120 mg to 1,500 mg and lasted 4 to 36 weeks [8]. A knee osteoarthritis trial used 500 mg twice a day for 8 weeks [9], and another used 500 mg three times a day for 28 days against diclofenac [10]. The trials in one knee meta-analysis ran for up to 16 weeks [3].
Safety and interactions
Common side effects: turmeric extracts had 12% fewer adverse events than NSAIDs and similar rates to placebo in the trials pooled in one meta-analysis [3].
Upper limits: no upper intake limit was found in the studies read. Hepatotoxicity has been seen in a few rodent studies with high-dose turmeric rhizome powder or extract [11].
Liver injury: rare cases have been reported, mostly with high-dose, high-absorption products and often with other medicines [12]. Reported injury typically starts after one to four months and usually resolves on stopping the product, and acute liver failure has been reported rarely [11]. A 2026 case report describes recurrent autoimmune-like hepatitis after restarting a turmeric product with black pepper extract [13].
Interactions: piperine inhibits CYP3A4 and P-glycoprotein, which may raise toxicity from drugs including warfarin and carbamazepine [14]. The same review says curcumin changes how the body handles amlodipine [14]. No clinical trial of curcumin with warfarin was found.
Pregnancy and breastfeeding: no human safety trials of turmeric or curcumin supplements in pregnancy or breastfeeding were found. A 2026 review says pregnant women need more attention in interaction research [15].
People with liver problems: the US Pharmacopeia advises consulting a health-care practitioner before use if there is a history of liver problems [11].
Caveats and open questions
The knee meta-analyses cited here ran trials for up to 16 weeks, so longer effects are not well tested [3]. Results vary widely between studies [3]. Some trial authors have ties to companies that make the products tested [9][16]. Absorption studies are small, at 30 and 12 people [1][17]. Liver injury evidence is case reports, so the rate cannot be estimated [12].
References
- Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.. J Nutr, 2021.
- The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.. Phytother Res, 2024.
- Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials.. Curr Rheumatol Rep, 2021.
- A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms.. Nutrients, 2022.
- Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: A double-blind, randomized, placebo-controlled trial.. Osteoarthritis Cartilage, 2026.
- Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.. Cytokine, 2023.
- Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis.. Front Immunol, 2023.
- Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.. Front Immunol, 2022.
- An Investigation into the Effects of a Curcumin Extract (Curcugen®) on Osteoarthritis Pain of the Knee: A Randomised, Double-Blind, Placebo-Controlled Study.. Nutrients, 2021.
- Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study.. Trials, 2019.
- Rarely reported cases of hepatotoxicity associated with turmeric- and curcuminoid-containing dietary supplements: a comprehensive review by USP.. Pharm Biol, 2026.
- Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports.. Br J Clin Pharmacol, 2021.
- Recurrent Drug-Induced Autoimmune-like Hepatitis due to Turmeric Supplementation.. J Investig Med High Impact Case Rep, 2026.
- The double-edged sword of nutraceuticals: comprehensive review of protective agents and their hidden risks.. Front Nutr, 2025.
- Interactions Among Drugs, Food, Beverages, Alcohol, Herbs, Phytochemicals, Nutraceuticals, and Micronutrients: A Current and Updated Review.. Cardiovasc Hematol Agents Med Chem, 2026.
- Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.. Arthritis Res Ther, 2019.
- Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments.. Mol Nutr Food Res, 2021.